Clinical Trials Browser

Phase NA × Small Cell Lung Carcinoma × irinotecan sucrosofate × Clear all

NCT06258642 2025-08-20

Irinotecan Liposome Combined With Anlotinib as Second-line Regimen for SCLC

Phase NA Recruiting

Small Cell Lung Carcinoma